Pamela Esposito, Director at Kymera Therapeutics, Inc. (KYMR), sold 27,000 shares at $47.75 ($1.3M) on 2024-09-17, disclosed to the SEC on 2024-09-17.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.75 | 6,350 | $303K | 23.3% |
| 2 | $47.75 | 6,350 | $303K | 23.3% |
| 3 | $48.75 | 7,150 | $349K | 26.7% |
| 4 | $48.75 | 7,150 | $349K | 26.7% |
| Total | $48.28 avg | 27,000 | $1.3M | 100% |
| Filing → |
| KYMR | SELL | 2026-01-20 | $707K | — | Filing → |
| KYMR | SELL | 2025-12-17 | $4.4M | — | Filing → |
| KYMR | SELL | 2025-06-03 | $245K | — | Filing → |